Odontogenic Epithelium: Immunolabeling of Ki-67, EGFR and Survivin in Pericoronal Follicles, Dentigerous Cysts and Keratocystic Odontogenic Tumors

Head and Neck Pathology

Volumn 5, Issue 1, 2011, Pages 1-7

  de Oliveira, Márcia Gaiger ^a   da Silva Lauxen, Isabel ^a   Chaves, Anna Cecília Moraes ^a   Rados, Pantelis Varvaki ^a   Filho, Manoel Sant'Ana ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Dentigerous cyst; EGFR; Epithelium; Immunohistochemistry; Keratocyst odontogenic tumor; Ki 67; Odontogenic cysts; Odontogenic lesions; Odontogenic tumors; Pericoronal follicles; Survivin

Indexed keywords

BIRC5 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; INHIBITOR OF APOPTOSIS PROTEIN; KI 67 ANTIGEN;

ARTICLE; BIOSYNTHESIS; EPITHELIUM; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; ODONTOGENIC TUMOR; PATHOLOGY; TERATOMA;

DENTIGEROUS CYST; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; KI-67 ANTIGEN; ODONTOGENIC TUMORS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 79951517594     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-010-0216-0     Document Type: Article

References (38)

1. Curran AE, Damm DD, Drummond JF. Pathologically significant pericoronal lesions in adults: histopathologic evaluation. J Oral Maxillofac Surg. 2002; 60: 613-7.
2. Aldelsperger J, Campbell JH, Coates DB, et al. Early soft tissue pathosis associated with impacted third molars without pericoronal radiolucency. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 89: 402-6.
3. Baumgart SC, Lauxen IS, Sant'Ana Filho M, et al. Epidermal growth factor receptor distribution in pericoronal follicles: relationship with the origin of odontogenic cysts and tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103: 240-5.
4. Edmatsu M, Kumanoto H, Ooya K, et al. Apoptosis-related factors in the epithelial components of pericoronal follicles and dentigerous cysts associated with impacted third molars of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 99: 17-23.
5. Payeras MR, Sant'Ana Filho M, Lauxen IS, et al. Quantitative analysis of argyrophilic nucleolar organizer regions and epidermal growth factor receptor in ameloblastomas. J Oral Pathol Med. 2007; 36(2): 99-104.
6. Kramer IRH, Pindborg JJ, Shear M. Histological typing of odontogenic tumours. Berlin, Germany: Springer; 1992.
7. Philipsen HP. Keratocyst odontogenic tumour. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Lyon, France: IARC Press; 2005.
8. Slootweg PJ. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions: an immunohistochemical study. J Oral Pathol Med. 1995; 24: 393-7.
9. Li TJ, Browne RM, Prime SS, et al. p53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med. 1996; 25: 249-55.
10. Stoelinga PJW. Etiology and pathogenesis of keratocyst: natural history and immunohistochemistry. Oral Maxillofac Surg Clin North Am. 2003; 15: 317-24.
11. Kichi E, Enokiya Y, Muramatsu T, et al. Cell proliferation, apoptosis and apoptosis-related factors in odontogenic keratocysts and in dentigerous cysts. J Oral Pathol Med. 2005; 34: 280-6.
12. Laimer K, Spizzo G, Gastl G, et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol. 2007; 43(2): 193-8.
13. Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys. 2004; 59: 21-6.
14. Lin SY, Makino K, Xia W, et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol. 2001; 3(9): 802-8.
15. Sah NK, Khan Z, Khan GJ, et al. Structural, functional and therapeutic biology of survivin. Cancer Lett. 2006; 244(2): 164-71.
16. Duffy MJ, O'Donovan N, Brennan DJ, et al. Survivin: a promising tumor biomarker. Cancer Lett. 2007; 249: 49-60.
17. Brennan DJ, Rexhepaj E, O'Brien SL, et al. Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer. Clin Cancer Res. 2008; 14(9): 2681-9.
18. Kumamoto H, Ooya K. Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas. Virchows Arch. 2004; 444: 164-70.
19. Andric M, Dozic B, Popovic B, et al. Survivin expression in odontogenic keratocysts and correlation with cytomegalovirus infection. Oral Dis. 2010; 16: 156-9.
20. Saraçoǧlu U, Kurt B, Günhan Ö, et al. MIB-1 expression in odontogenic epithelial rests, epithelium of health oral mucosa and epithelium of selected odontogenic cysts: an immunohistochemical study. Int J Oral Maxillofac Surg. 2005; 34: 432-5.
21. Lo Muzio L, Staibano S, Pannone G, et al. Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res. 1999; 78: 1345-53.
22. De Paula AMB, Carvalhais JN, Domingues MG, et al. Cell proliferation markers in the odontogenic keratocyst: effect of inflammation. J Oral Pathol Med. 2000; 29: 477-82.
23. Kaplan I, Hirshberg A. The correlation between epithelial cell proliferation and inflammation in odontogenic keratocyst. Oral Oncol. 2004; 40: 985-91.
24. Damjanov I, Mildner B, Knowles BB. Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues. Lab Invest. 1986; 55: 588-92.
25. Gulkesen KH, Kilicarslan B, Altunbas HA, et al. EGFR and p53 expression and proliferative activity in parathyroid adenomas: an immunohistochemical study. APMIS. 2001; 109: 870-4.
26. Lo Muzio L, Pannone G, Leonardi R, et al. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res. 2003; 82: 923-8.
27. Lo Muzio L, Farina A, Rubini C, et al. Survivin as prognostic factor in squamous cell carcinoma of the oral cavity. Cancer Lett. 2005; 225: 27-33.
28. Tanaka C, Uzawa K, Shibahana T, et al. Expression of an inhibitor of apoptosis, Survivin, in oral carcinogenesis. J Dent Res. 2003; 82: 607-11.
29. Pizen J, Cör A, Gale N. Survivin expression is a negative marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology. 2004; 45: 180-6.
30. Suzuki T, Kumanoto H, Kunimore K, et al. Immunohistochemical analysis of apoptosis-related factors in lining epithelium of radicular cysts. J Oral Pathol Med. 2005; 34: 46-52.
31. Thosaporn W, Iamaroon A, Pongsiriwets S, et al. A comparative study of epithelial cell proliferation between the odontogenic keratocysts, orthokeratinized odontogenic cyst and ameloblastoma. Oral Dis. 2004; 10: 22-6.
32. Oliveira MG, Lauxen IS, Chaves ACM, et al. Immunohistochemical analysis of the patterns of p53 and PCNA expression in odontogenic cystic lesions. Med Oral Patol Oral Cir Bucal. 2008; 13(5): E275-80.
33. Gurgel CAS, Ramos EAG, Azevedo RA, et al. Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemistry study. J Mol Histol. 2008; 39: 311-6.
34. Gadbail AR, Chaudhary M, Patil S, et al. Actual Proliferating Index and p53 protein expression as prognostic marker in odontogenic cysts. Oral Dis. 2009; 15: 490-8.
35. Piatelli A, Lezzi G, Fioroni M, et al. Ki-67 expression in dentigerous cysts, unicystic ameloblastoma and ameloblastomas arising from dental cysts. J Endod. 2002; 28(2): 55-8.
36. Fortugno P, Wall NR, Giodini A, et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci. 2002; 1151: 575-85.
37. De Maria S, Pannone G, Bufo P, et al. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2009; 135(1): 107-16.
38. Li F. Role of surviving and its splice variants in tumorigenesis. Br J Cancer. 2005; 92(2): 212-6.